Director Corporate Counsel - Transactions
Regeneron Pharmaceuticals
Summary
As a member of the Contracts Group in the Regeneron Law Department's Transactions Law Group, the Director, Corporate Counsel, will draft, review and negotiate a wide array of contracts for various of Regeneron's functions, potentially including its research and development, commercial, real estate and facilities and G&A business units, as well as developing privacy expertise in order to assist other members of the Transactions Law Group in negotiating privacy terms in contracts and provide related advice and counsel.
Job description
When & where
- Work Location: Sleepy Hollow, NY
- Work model/flexibility: 4 days per week on site
Discover your role
- Providing legal support for a broad set of business transactions, which may include research collaboration agreements, master services agreements, leases, construction contracts, consulting services agreements, license agreements, data use agreements, laboratory services agreements and confidentiality agreements, among others. Advising on other current and potential legal, clinical, and commercial issues with industry specific knowledge and transactional guidance.
- Developing subject matter expertise in data privacy laws and the Regeneron privacy policies and advising Transaction Law colleagues and clients on developments of importance and over time serving as a resource to: assist members of the Transactions Law Group to negotiate and finalize data privacy language in third-party agreements; managing updates to the group's data privacy contracting playbook, creating data privacy contracting tools and training materials and acting as a liaison to the Data Privacy Office on data privacy policy questions and approaches.
- Working collaboratively with other organization groups, including the Privacy Group, the Compliance Group, Risk Management and Global Procurement.
- Advising on other current and potential legal and business issues with industry specific knowledge and transactional guidance.
- Providing strategic direction and oversight for Regeneron's contract lifecycle management system, including serving as the supervisor of the team's Associate Director, Contracts Systems and Operations.
- Have a history of self-motivation and working independently on projects, while meeting deadlines and prioritizing multiple matters in a high volume and fast-paced environment.
This role requires
- JD with excellent law school credentials
- Licensed to practice law in New York or be eligible for licensure as a registered in-house counsel is preferred
- 6+ years legal experience at a law firm and/or in-house, including experience or familiarity with biotechnology, pharmaceuticals and/or healthcare
- Excel at advising clients regarding all aspects of contract law and related areas.
Requirements
- JD with excellent law school credentials
- Licensed to practice law in New York or eligible for licensure as registered in-house counsel (preferred)
- 6+ years legal experience at a law firm and/or in-house
- Experience or familiarity with biotechnology, pharmaceuticals and/or healthcare
- Excel at advising clients regarding all aspects of contract law and related areas
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.